The global direct-to-consumer (DTC) genetic testing market is experiencing rapid growth, driven by advancements in technology and increasing accessibility. Valued at USD 1,485.1 million in 2022 and estimated to reach USD 1,645.5 million in 2023, the market is projected to grow at an impressive compound annual growth rate (CAGR) of 11.4% from 2023 to 2033. By 2033, the market size is expected to total USD 4,843.4 million.
Rising consumer interest in genealogy, personalized health insights, and ancestry exploration has fueled the popularity of DTC genetic testing. Technological advancements have made these services more affordable and accessible, driving adoption worldwide.
Future Market Insights highlights that consumer demand for convenient, direct-to-door genetic insights is reshaping healthcare and lifestyle decision-making. With a growing emphasis on preventive care and personalized medicine, DTC genetic testing is poised to play a significant role in shaping the future of health diagnostics.
Get Full Report Now – https://www.futuremarketinsights.com/reports/direct-to-consumer-genetic-testing-market
Key Takeaways:
- The DTC genetic testing market is forecast to grow at a CAGR of 11.4%, reaching USD 4,843.4 million by 2033.
- Advancements in technology make genetic testing more accessible and economical, boosting market adoption.
- Consumer interest in genealogy, ancestry, and personalized health drives market growth.
- DTC genetic testing supports preventive healthcare and personalized medicine, redefining diagnostic paradigms.
Market Drivers
- Advancements in Technology: Recent technological developments have made genetic testing more accessible and affordable, contributing to its rising popularity.
- Increased Public Awareness: Growing awareness about health and genealogy has led consumers to seek out genetic testing services.
- Health Management and Personalization: Consumers are increasingly interested in understanding their genetic predispositions to various health conditions, which can aid in personalized health management.
- Ease of Access: DTC genetic tests are marketed directly to consumers through various channels, making them easily accessible without the need for healthcare provider intermediaries.
Competitive Landscape
Some of the prominent players in the global market are-
- 23andMe
- Ancestry DNA
- Color Genomics, Inc.
- Genetic Technology (EasyDNA)
- Full Genomes Corporation, Inc.
- Helix OpCo LLC
- IDENTIGENE, LLC/ DNA Diagnostics Center
- Living DNA Ltd
- MyHeritage Ltd
- Prenetics Limited
- Family Tree DNA
- Interleukin Genetics/orig3n
- Counsyl/Myriad Genetics, Inc.
- Veritas Genetics
- Fulgent Genomics
Some of the recent industry developments in the global direct-to-consumer genetic testing market are:
- In January 2022, 23andMe Holding Co., a leading consumer genetics and research company, received FDA clearance for a genetic health risk report on a hereditary prostate cancer marker.
- In August 2021, Ancestry, a global leader in family history, announced that it has agreed to acquire Geneanet, a renowned French genealogy company. With over 30 billion records from more than 80 countries, Ancestry helps customers discover new details about their family stories and ancestors.
- In June 2023, Prenetics Global Limited, a leading genomics and precision oncology company, announced financial results for the first quarter ending March 31, 2023, along with recent business updates.
Direct-to-Consumer Genetic Testing Market Outlook by Category
By Product:
- Pharmacogenetics Tests
- Carrier Screening Tests
- Genetic Health Risk (GHR) Tests
- Cancer Predisposition Tests
- Low-Risk General Wellness Tests
- Ancestry Tests
By Technology:
- Single Nucleotide Polymorphism Chip
- Whole Genome Sequencing
By Sample:
- Saliva
- Urine
- Blood
By Sales Channel:
- Institutional Sales
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Others
- Retail Sales
- Retail Pharmacies
- Online Sales
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- Middle East and Africa
Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:
CRBSI Treatment Market
Vessel-sealing Devices Market
Checkpoint Inhibitor Refractory Cancer Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube